Paul Manby

Presented at #ASCO25: In resectable gastric and gastroesophageal junction cancer, adding durvalumab to perioperative chemotherapy improved event-free survival and pathological complete response, with no major increase in high-grade adverse events. Full MATTERHORN trial results: nej.md/437IXTF

Presented at #ASCO25: A 3-year structured exercise program after adjuvant chemotherapy for colon cancer improved disease-free and overall survival, physical functioning, and fitness, as compared with health education alone. Full CHALLENGE phase 3 trial results: nej.md/4mh5RPL @ASCO

Gastric cancer - state of the art review ‼️🆕 @TheLancet 1️⃣ Global incidence and mortality 2️⃣ Surgical management 3️⃣ Treatment for advanced disease 4️⃣ Current and future treatments 📸: thelancet.com/journals/lance…

Last but not least: state data analysis by @PeiWenLimMD @ZhiVenFongMD of 5446 patients undergoing bailout for severe cholecystitis showed conversion to open had the highest bile duct injury rate (4.4%) vs subtotal cholecystectomy (0.5%) or cholecystostomy tube (0.2%) #AmerSurg25

Omental preservation versus omentectomy in curative-intent gastrectomy for gastric cancer: Swedish population-based cohort study ➡️doi.org/10.1093/bjsope… This Swedish population-based cohort study showed similar survival and surgical outcomes after gastrectomy with omental preservation compared with gastrectomy with omentectomy. These results suggest that omentectomy can be omitted for patients with gastric cancer undergoing curative-intent gastrectomy. 👏👏👏Biying Huang , Chih-Han Kung , Andrianos Tsekrekos , Fredrik Klevebro , Raphaela Mayerhofer , Laura Vossen Engblom , Mats Lindblad , Jakob Hedberg , Eva Szabo , David Edholm , Ulrika Smedh , Jan Johansson , Ioannis Rouvelas , @MagnusNsurgonc #SoMe4Surgery #MedTwitter #SurgEd #Surgery @BJSAcademy @BJSurgery @young_bjs @juliomayol @JJEarnshaw @OUPMedicine #some4UGI #uppergi #gastriccancer @ISDE_net @Augishealth @roux_group @T4UGIS #ESDE @Young_ESDE

#EditorsChoice #OpenAccess What is the impact of vertical depth of tumour on lymph node metastases among patients with T1b esophageal cancer? Is there a threshold depth that predicts the presence of nodal disease? academic.oup.com/dote/article/3…

Pleased to receive this recognition from @RCSnews for our RCS laparoscopic course at @BTHFT The course achieved high participant and faculty score from the impressive feedbacks. Looking forward to our next course in October. @BTHFTsimtech @BEaT_BTHFT

Thrilled to get brilliant feedbacks from candidates to our first @RCSnews RCS intermediate lap skills course done at @BTHFT which normally runs in London. Pleased to be a regional center for this valuable course. Thanks for all faculty and for @BTHFTsimtech team.

Pleased to participate in our first Basic Robotic skills course at Bradford Teaching Hospitals NHS Foundation Trust @BTHFT. Esteemed faculty and impressive feedbacks.. Thanks for Peter Webster for organising the course. Thanks for Intuitive and Jessica Higgins for support

@rbarbosa91 🙋‍♂️🤖 centrist here! Love it for operating in a tight space eg minimally invasive esophagectomy/Heller’s/Giant hiatal hernia. But find it more cumbersome and not ideally suited to bariatrics etc.

The entire conversation on robotic surgery is too polarizing… the critics don’t use the 🤖at all and the supporters feel like it needs to be used for everything IMO there needs to be more robot ‘centrists’ out there who will say it’s good for some things and not others.

Pleased to announce for the first RCS Intermediate lap course @BTHFT joined by esteemed faculty. A great chance to develop lap skills for ST3-5 and SAS doctors. Booking details attached @BTHFTsimtech @RCSnews @clinskills

Most awaited trial for last decade Peroperative FLOT vs neoadjuvant CROSS for adenocarcinoma of esophagus. What will work the best ? FlOT has Sunk the Cross . ✝️ Median OS 66 months vs 33 months 3 year OS -57.4 % vs 50 .7 % HR of 0.7 FOLT is the winner over Cross . @ASCO #asco24 @agrothey @GlopesMd @weoncologists @GIcancerDoc @Larvol @OncoAlert @OncBrothers

Amazing news! Another SARONG site is now open! Congratulations to @BRI_GI_research @CityOfResearch @BTHFT! Welcome to @ahmedelshaer387 and his team, looking forward to working with you!

using the "Archimedes technique" during robotic repair for that incarcerated hernia that won't reduce - irrigation directly into the hernia defect

Very pleased to share a 🧵on our new paper just published in @BJSurgery exploring prognostication using a novel composite marker: 'Cachexia Index' in patients with locally advanced oesophagogastric cancer. (1/8) Link: academic.oup.com/bjs/article/11…

"Risk of lymph node metastasis in T1 esophageal adenocarcinoma: a meta-analysis" #EsophagealCancer #OpenAccess academic.oup.com/dote/advance-a…

Endoscopy and Antireflux Surgery: A Technical Review of Pre- and Postoperative Evaluation and Recognizing Patterns of Failure 📕Read Here 🔓Open Access: journals.sagepub.com/doi/full/10.11… #GITwitter #MedTwitter @AHNesophagus @AHNSurgeryInst @Dunn4Gut @Sayazi @SvenESEriksson @JobeBlair

Excellent paper summarising the current debate/questions remaining around neoadjuvant treatment for oesophageal cancer.

Peri-operative chemo is better than preoperative chemoradiotherapy for gastro-oesophageal junctional adenocarcinomas: A 10-year study reveals surprising results. Read the article at bit.ly/46YSR8T @manukwij @essonews @BASO_ACS @ogsurgery @T4UGIS

🚨 🚨 🚨 Should cancers of the esophagogastric junction be managed as esophageal cancers or gastric cancers? What is the adequate lymphadenectomy template? NACTRT vs FLOT? Are they a different entity altogether requiring a unique approach? Lets explore…🧵